BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 32374033)

  • 1. Chilblain-like lesions in children following suspected COVID-19 infection.
    Colonna C; Monzani NA; Rocchi A; Gianotti R; Boggio F; Gelmetti C
    Pediatr Dermatol; 2020 May; 37(3):437-440. PubMed ID: 32374033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chilblains in children in the setting of COVID-19 pandemic.
    Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A
    Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
    Kanitakis J; Lesort C; Danset M; Jullien D
    J Am Acad Dermatol; 2020 Sep; 83(3):870-875. PubMed ID: 32502585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chilblain-like lesions during the COVID-19 pandemic: early or late sign?
    Recalcati S; Fantini F
    Int J Dermatol; 2020 Aug; 59(8):e268-e269. PubMed ID: 32572958
    [No Abstract]   [Full Text] [Related]  

  • 5. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
    Piccolo V; Neri I; Manunza F; Mazzatenta C; Bassi A
    Int J Dermatol; 2020 Aug; 59(8):1026-1027. PubMed ID: 32496583
    [No Abstract]   [Full Text] [Related]  

  • 6. Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic.
    Colonna C; Genovese G; Monzani NA; Picca M; Boggio F; Gianotti R; Marzano AV
    J Am Acad Dermatol; 2020 Sep; 83(3):965-969. PubMed ID: 32534082
    [No Abstract]   [Full Text] [Related]  

  • 7. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
    Colmenero I; Santonja C; Alonso-Riaño M; Noguera-Morel L; Hernández-Martín A; Andina D; Wiesner T; Rodríguez-Peralto JL; Requena L; Torrelo A
    Br J Dermatol; 2020 Oct; 183(4):729-737. PubMed ID: 32562567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.
    Le Cleach L; Dousset L; Assier H; Fourati S; Barbarot S; Boulard C; Bourseau Quetier C; Cambon L; Cazanave C; Colin A; Kostrzewa E; Lesort C; Levy Roy A; Lombart F; Marco-Bonnet J; Monfort JB; Samimi M; Tardieu M; Wolkenstein P; Sbidian E; Beylot-Barry M;
    Br J Dermatol; 2020 Nov; 183(5):866-874. PubMed ID: 32628270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient.
    Santonja C; Heras F; Núñez L; Requena L
    Br J Dermatol; 2020 Oct; 183(4):778-780. PubMed ID: 32585767
    [No Abstract]   [Full Text] [Related]  

  • 10. Chilblain-like lesions during the COVID-19 pandemic: a serological study on a case series.
    Rizzoli L; Collini L; Magnano M; Termine S; Barcelli R; Infusino SD; Bauer P; Rech G; Girardelli CR; Balestri R
    Br J Dermatol; 2020 Oct; 183(4):782-784. PubMed ID: 32613620
    [No Abstract]   [Full Text] [Related]  

  • 11. New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus.
    Battesti G; El Khalifa J; Abdelhedi N; Ferre V; Bouscarat F; Picard-Dahan C; Brunet-Possenti F; Collin G; Lavaud J; Le Bozec P; Rousselot M; Tournier A; Lheure C; Couvelard A; Hacein-Bey-Abina S; Abina AM; Charpentier C; Mignot S; Nicaise P; Descamps D; Deschamps L; Descamps V
    J Am Acad Dermatol; 2020 Oct; 83(4):1219-1222. PubMed ID: 32622895
    [No Abstract]   [Full Text] [Related]  

  • 12. Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients.
    Piccolo V; Bassi A; Argenziano G; Mazzatenta C; Guglielmo A; Patrizi A; Neri I
    J Am Acad Dermatol; 2020 Dec; 83(6):1749-1751. PubMed ID: 33010953
    [No Abstract]   [Full Text] [Related]  

  • 13. Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France.
    de Masson A; Bouaziz JD; Sulimovic L; Cassius C; Jachiet M; Ionescu MA; Rybojad M; Bagot M; Duong TA;
    J Am Acad Dermatol; 2020 Aug; 83(2):667-670. PubMed ID: 32380219
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythema multiforme-like lesions in children and COVID-19.
    Torrelo A; Andina D; Santonja C; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I
    Pediatr Dermatol; 2020 May; 37(3):442-446. PubMed ID: 32445583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak.
    Fernandez-Nieto D; Jimenez-Cauhe J; Suarez-Valle A; Moreno-Arrones OM; Saceda-Corralo D; Arana-Raja A; Ortega-Quijano D
    J Am Acad Dermatol; 2020 Jul; 83(1):e61-e63. PubMed ID: 32339703
    [No Abstract]   [Full Text] [Related]  

  • 16. All that glisters is not COVID: Low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions.
    Denina M; Pellegrino F; Morotti F; Coppo P; Bonsignori IM; Garazzino S; Ravanini P; Avolio M; Cavallo R; Bertolotti L; Felici E; Acucella G; Montin D; Rabbone I; Licciardi F
    J Am Acad Dermatol; 2020 Dec; 83(6):1751-1753. PubMed ID: 32781180
    [No Abstract]   [Full Text] [Related]  

  • 17. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
    Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
    J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain.
    Caselli D; Chironna M; Loconsole D; Nigri L; Mazzotta F; Bonamonte D; Aricò M
    Br J Dermatol; 2020 Oct; 183(4):784-785. PubMed ID: 32613638
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous lesions in a patient with COVID-19: are they related?
    Ahouach B; Harent S; Ullmer A; Martres P; Bégon E; Blum L; Tess O; Bachmeyer C
    Br J Dermatol; 2020 Aug; 183(2):e31. PubMed ID: 32353170
    [No Abstract]   [Full Text] [Related]  

  • 20. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.
    Kerber AA; Soma DB; Youssef MJ
    Int J Dermatol; 2020 Aug; 59(8):1024-1025. PubMed ID: 32496578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.